# Rocket Pharmaceuticals, Inc.: Form 8-K, filed Aug 27, 2026

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: 8-K
- Filed: 2026-08-27
- Accepted by EDGAR: Aug 27, 2026, 16:06 ET
- Period: 2026-08-21
- Accession: 0001140361-26-034689
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036126034689/ef20081170_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036126034689/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036126034689/ef20081170_8k.htm

Filed Aug 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-034689. Last ingested by Listed: Oct 30, 2026, 13:58 ET. No prices; not investment advice.